ENDOCYTE INC (ECYT) Fundamental Analysis & Valuation

NASDAQ:ECYT • US29269A1025

Current stock price

23.99
-0.01 (-0.04%)
At close:
23.99
0 (0%)
After Hours:

This ECYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for ECYT not available.

ECYT Fundamentals: All Metrics, Ratios and Statistics

ENDOCYTE INC

NASDAQ:ECYT (12/20/2018, 8:20:46 PM)

After market: 23.99 0 (0%)

23.99

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners75.62%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner Change0%
Market Cap1.97B
Revenue(TTM)128.80K
Net Income(TTM)-41.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15289.9
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB N/A
EV/EBITDA -36.67
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS4.23
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.64%
ROE -11.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -33918.79%
PM (TTM) -32095.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 45.77
Quick Ratio 45.77
Altman-Z 146.99
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.33%
EPS Next Y36%
EPS Next 2Y14.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84%
Revenue growth 3YN/A
Revenue growth 5Y-71.19%
Sales Q2Q%164.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ENDOCYTE INC / ECYT Fundamental Analysis FAQ

What is the fundamental rating for ECYT stock?

ChartMill assigns a fundamental rating of 4 / 10 to ECYT.


What is the valuation status for ECYT stock?

ChartMill assigns a valuation rating of 1 / 10 to ENDOCYTE INC (ECYT). This can be considered as Overvalued.


What is the profitability of ECYT stock?

ENDOCYTE INC (ECYT) has a profitability rating of 3 / 10.


What is the financial health of ENDOCYTE INC (ECYT) stock?

The financial health rating of ENDOCYTE INC (ECYT) is 8 / 10.